Remove Biotech Remove Contract research organization Remove Partnering capability and readiness
article thumbnail

Frost & Sullivan Awards Avance Clinical for Global Biotech CRO Excellence, Highlighting Agility, Responsiveness, Customer Value, and Proven Ability to Expedite Quality Clinical Programs

Frost & Sullivan

. – 27 th August 2024 – Frost & Sullivan recently assessed the biotech contract research organization (CRO) industry and, based on its results, recognizes Avance Clinical with the 2024 Global Customer Value Leadership Award.

Biotech 52
article thumbnail

Shaping the Future of Biotech Trials: An Interview with John Moller, CEO of Novotech

Frost & Sullivan

In this exclusive conversation, John Moller , CEO of Novotech , shares how the companys Asia-Pacific roots, global expansion strategy, and deep biotech specialization position it to become the CRO of choice for biotech and small to mid-sized pharmaceutical companies worldwide. What makes us unique?

Biotech 52